STAASTAAR Surgical Company

$860M

Q4 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$59M+28.3% YoY

Gross Profit

$45M76.3% margin

Operating Income

$7M12.5% margin

Net Income

$5M8.3% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

+1.1%

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

$4M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$346M

Total Liabilities

$87M

Stockholders' Equity

$259M

Cash & Equivalents

$200M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$59M	$46M	+28.3%
Gross Profit	$45M	$34M	+31.2%
Operating Income	$7M	$4M	+81.1%
Net Income	$5M	$3M	+47.9%

Revenue Segments

Implantable Collamer Lenses

$53M81%

Cataract Intraocular Lenses

$10M15%

Other Surgical Products

$3M4%

STAA Q4 2021 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena